Skip to main content

Table 4 ORs (95% CIs) of NAFLD and hepatic fibrosis according to the quartiles of PHR

From: Association between the platelet/high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease: results from NHANES 2017–2020

PHR quartiles

Model 0

P value

Model 1

P value

Model 2

P value

Model 3

P value

NAFLD

 Q1

1-reference

-

1-reference

-

1-reference

-

1-reference

-

 Q2

1.52(1.32–1.76)

 < 0.001

1.68(1.45–1.95)

 < 0.001

1.68(1.45–1.95)

 < 0.001

1.44(1.14–1.83)

0.003

 Q3

2.53(2.21–2.91)

 < 0.001

2.99(2.58–3.47)

 < 0.001

2.99(2.58–3.47)

 < 0.001

1.95(1.50–2.52)

 < 0.001

 Q4

3.74(3.25–4.30)

 < 0.001

4.75(4.08–5.54)

 < 0.001

4.75(4.08–5.54)

 < 0.001

2.36(1.76–3.18)

 < 0.001

Hepatic fibrosis

 Q1

1-reference

-

1-reference

-

1-reference

-

1-reference

-

 Q2

1.11(0.87–1.42)

0.417

1.22(0.95–1.57)

0.116

1.22(0.95–1.57)

0.116

0.77(0.52–1.13)

0.180

 Q3

1.62(1.29–2.04)

 < 0.001

1.84(1.45–2.34)

 < 0.001

1.84(1.45–2.34)

 < 0.001

0.89(0.59–1.34)

0.570

 Q4

1.68(1.34–2.12)

 < 0.001

2.00(1.57–2.55)

 < 0.001

2.00(1.57–2.55)

 < 0.001

0.66(0.41–1.06)

0.088

  1. Model 0: unadjusted model
  2. Model 1: adjusted for age, sex, ethnicity, education, PIR, smoking status
  3. Model 2: additionally adjusted for diabetes and hypertension
  4. Model 3: additionally adjusted for HbA1c, TG, TC, LDL-C